The Beauty Health Company (SKIN) Financials
SKIN Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 929.1 million | 869.7 million |
2023-09-30 | 973.1 million | 883.2 million |
2023-06-30 | 1.0 billion | 845.6 million |
2023-03-31 | 994.9 million | 847.3 million |
SKIN Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -7.3 million | 2.3 million |
2023-09-30 | 15.1 million | 8.2 million |
2023-06-30 | 18.7 million | 8.5 million |
2023-03-31 | -17.8 million | 3.6 million |
SKIN Net Income
No data available :(
SKIN Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 523.0 million | - | 13.9 million |
2023-09-30 | 559.4 million | - | 14.8 million |
2023-06-30 | 549.7 million | 736.3 million | 15.5 million |
2023-03-31 | 532.3 million | 735.2 million | 17.2 million |
SKIN Shares Outstanding
SKIN Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 2.2 million | 3.0 million | 29.0 million | 32.0 million |
2023-09-30 | 2.9 million | 1.8 million | 37.0 million | 30.7 million |
2023-06-30 | 3.2 million | 2.9 million | 35.1 million | 43.0 million |
2023-03-31 | 4.8 million | 2.3 million | 30.4 million | 38.7 million |
SKIN Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 96.8 million | 51.1 million |
2023-09-30 | 97.4 million | 110.0 million |
2023-06-30 | 117.5 million | 49.6 million |
2023-03-31 | 86.3 million | 32.2 million |
SKIN
Price: $3.24
52 week price:
Earnings Per Share: -0.76 USD
P/E Ratio: -4.25
Exchange: NCM
Sector: Consumer Defensive
Industry: Household & Personal Products
Volume: 2.4 million
Market Capitalization: 451.7 million